Literature DB >> 20576508

Microcapillary specifically designed for pressure microinjections of very low volumes.

Zsolt István Kovács1, Miklós Palkovits.   

Abstract

Tracer micronjections are very widely used in brain mapping research. While administration of small quantities/volumes of tracers can easily be achieved through iontophoresis, in the case of pressure injections the volume of the substances injected are much more difficult to control. Instead of using different variables like hydrodynamic conductance, pressure pulses, pressure-temperature-dependent protocols to quantify very small volumes in the nanoliter range out of a higher volume, within the confines of the present study a novel microcapillary design is presented. This microcapillary contains exactly the volume of tracer one intends to inject, therefore the danger of flooding large brain areas or the risk of tracer leakage to neighbouring nuclei are completely eliminated, and in the same time this design assures that very small and circumscribed areas can be labeled and their connections mapped, thus making the experiments more specific. In combination with high precision stereotaxic measurements these small volumes of tracers can yield well targeted and very discrete injection sites that make possible the mapping of individual nuclear subdivisions or delicate nuclei in the brain. Copyright 2010 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20576508     DOI: 10.1016/j.jneumeth.2010.05.016

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  2 in total

1.  Intracranial landmarks and other techniques to further improve the precision of stereotaxic tracer injections.

Authors:  Zsolt I Kovács; Miklós Palkovits
Journal:  Exp Brain Res       Date:  2010-10-27       Impact factor: 1.972

2.  A discrete dopaminergic projection from the incertohypothalamic A13 cell group to the dorsolateral periaqueductal gray in rat.

Authors:  Fany Messanvi; Ellie Eggens-Meijer; Benno Roozendaal; Johannes J van der Want
Journal:  Front Neuroanat       Date:  2013-12-06       Impact factor: 3.856

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.